Gene Polymorphisms and Chemotherapy in Non-small Cell Lung Cancer

Gene Polymorphisms and Chemotherapy in Non-small Cell Lung Cancer

The phamacogenetics is being used to predict whether the selected chemotherapy will be really effective and tolerable to the patient. Irinotecan, oxidized by CYP3A4 to produce inactive compounds, is used for treatment of various cancers including advanced non small cell lung cancer (NSCLC) patients....

Full description

Bibliographic Details
Main Author: Kayo OSAWA
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2009-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Genetic polymorphism
Drug therapy
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2009.08.001&path%5B%5D=979

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2009.08.001&path%5B%5D=979

Similar Items